Abstract
Idiopathic intracranial hypertension (IIH) is a kind of familiar disease for neurological physicians, a syndrome which takes headaches, optical disk edema, and some other signs and symptoms related to increased intracranial pressure as the main clinical manifestations, while imaging examination shows no intracranial space-occupying lesions, vascular lesions, hydrocephalus, or other related intracranial lesions, with normal cerebrospinal fluid composition. In the past, patients with IIH could only be related to ophthalmology for evaluation of optic nerve morphology and status of visual field. However, by integrating lamina cribrosa district into the whole optic nerve pathways by ophthalmologists, people gradually realize that the cerebrospinal fluid circulation around the optic nerve is also related to the eye disease, such as glaucoma. It may provide a good control model for the study of glaucoma. We hope that this chapter, on the one hand, can make eye doctor know more about IIH, including the historical evolution, epidemiology, pathogenesis, clinical manifestation, standard diagnosis, and treatment of this disease; on the other hand, we hope to inspire the reader to recognize the eye diseases from the perspective of craniocerebral diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Quincke H. Meningitis serosa. Sammlung klinischer Vortrage Innere Medizin. 1893;67:655.
Nonne M. Uber Falle vom Symtomkomplex “Tumor Cerebri” mit Ausgang in Heilung “Pseudotumor Cerebri”. Deutsch Z Nervenheilkunde. 1904;27:169–216.
Symonds CP. Otitic hydrocephalus. Brain. 1931;54:55–71.
Dandy WE. Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg. 1937;106:492–513.
Foley J. Benign forms of intracranial hypertension: “toxic” and “otitic” hydrocephalus. Brain. 1955;78:1–41.
Buchheit WA, Burton C. Nomenclature in intracranial pressure. N Engl J Med. 1969;281(1):47.
Buchheit WA, Burton C, Haag B, Shaw D. Papilledema and idiopathic intracranial hypertension. N Engl J Med. 1969;280(17):938–42.
Corbett JJ, Thompson HS. The rational management of idiopathic intracranial hypertension. Arch Neurol. 1989;46:1049–51.
Smith JL. Whence pseudotumor cerebri? J Clin Neuroophthalmol. 1985;5:55–6.
Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59:1492–5.
Friedman DI. The pseudotumor cerebri syndrome. Neurol Clin. 2014;32:363–96.
Wakerley B, Tan M, Ting E. Idiopathic intracranial hypertension. Cephalalgia. 2015;35(3):248–61.
Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain. 1991;114:155–80.
Kupersmith MJ, Gamell L, Turbin R, et al. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology. 1998;50:1094–8.
Tomsak RL, Niffenegger AS, Remler BF. Treatment of pseudotumor cerebri with Diamox (acetazolamide). J Clin Neuroophthalmol. 1988;18:93–8.
Celebisoy N, Gökc a F, Sirin H, et al. Treatment of idiopathic intracranial hypertension: Topiramate vs. acetazolamide, an open-label study. Acta Neurol Scand. 2007;116:322–7.
Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol. 1994;9:130–4.
Liu GT, Glaser JS, Schatz N. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol. 1994;118:88–96.
Fridley J, Foroozan R, Sherman V, et al. Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg. 2011;114:34–9.
Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology. 1997;49:734–9.
Sinclair AJ, Kuruvath S, Sen D, et al. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia. 2011;31:1627–33.
Banta JT, Farris BK. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology. 2000;107:1907–12.
Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for Pseudotumor cerebri. Arch Ophthalmol. 1993;111:632–5.
Bateman GA, Stevens SA, Stimpson J. A mathematical model of idiopathic intracranial hypertension incorporating increased arterial inflow and variable venous outflow collapsibility. J Neurosurg. 2009;110:446–56.
Higgins JN, Cousins C, Owler BK, et al. Idiopathic intracranial hypertension: 12 cases treated by venous sinus stenting. J Neurol Neurosurg Psychiatry. 2003;74:1662–6.
Donnet A, Metellus P, Levrier O, et al. Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients. Neurology. 2008;70:641–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China
About this chapter
Cite this chapter
Fu, J., Sun, Y. (2020). Idiopathic Intracranial Hypertension and Optic Nerve Damage. In: Wang, N. (eds) Integrative Ophthalmology. Advances in Visual Science and Eye Diseases, vol 3. Springer, Singapore. https://doi.org/10.1007/978-981-13-7896-6_4
Download citation
DOI: https://doi.org/10.1007/978-981-13-7896-6_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7895-9
Online ISBN: 978-981-13-7896-6
eBook Packages: MedicineMedicine (R0)